(NYSE: PFE) Pfizer's forecast annual revenue growth rate of -0.33% is not forecast to beat the US Drug Manufacturers - General industry's average forecast revenue growth rate of 7.23%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 9.9%.
Pfizer's revenue in 2025 is $62,463,000,000.On average, 5 Wall Street analysts forecast PFE's revenue for 2025 to be $359,574,454,420,382, with the lowest PFE revenue forecast at $357,843,618,777,173, and the highest PFE revenue forecast at $363,630,001,939,922. On average, 5 Wall Street analysts forecast PFE's revenue for 2026 to be $358,196,071,646,008, with the lowest PFE revenue forecast at $353,720,705,360,792, and the highest PFE revenue forecast at $364,351,400,923,160.
In 2027, PFE is forecast to generate $350,633,756,520,212 in revenue, with the lowest revenue forecast at $345,714,630,394,834 and the highest revenue forecast at $355,233,012,606,934.